Return to top of page

Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move Toward Earlier Detection and Intervention, How Will Researchers Adapt to this Evolution?


June 25, 2014
4:15-5:15 PM PT


111 W. Harbor Dr., Room 31A
San Diego, CA


If realized, disease-modifying interventions targeted toward Alzheimer’s disease – treatments which actually slow or halt disease progression – would be a tremendous breakthrough for patients, family members and researchers. Research into disease-modifying interventions is increasingly targeted toward earlier stage patients. Although early intervention may offer the most promise for patients, this earlier focus creates challenges for researchers who have traditionally been asked to provide co-primary outcome measures which demonstrate both the cognitive as well as functional impacts of therapy.

In order to identify the appropriate clinical trial endpoints – those which demonstrate clinical meaningfulness of treatment effects in the earlier stages of disease – a robust dialogue between researchers, regulators, patients, and caregivers must take place.

In this session, a panel of notable researchers, informed advocates, and regulatory experts will present an overview of the current paradigm, discuss the anticipated challenges as research focuses earlier, and debate future requirements.


Melissa Stevens, Deputy Executive Director, FasterCures


Cynthia Bens, Vice President of Public Policy, Alliance for Aging Research

Richard C. Mohs, PhD, Distinguished Research Fellow, Neuroscience and Medical Research, Eli Lilly and Company

Lon S. Schneider, MD, MS, Professor, Psychiatry, Neurology, and Gerontology, USC Keck School of Medicine

Living Longer and Loving It

Sign up for our monthly e-mail newsletter for the latest information on
scientific research on aging and health.

Ways to Give

There are many ways you can help accelerate the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health:

Platinum Transparency 2024 logo

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator Four-Star Rating Badge

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.